Aleafia Health Announces new President of Clinic Operations
White to Lead Integration of Canabo Medical Clinics and GrowWise Health Post-closing of Emblem Acquisition Previously the COO of Canada’s Largest Multidisciplinary Clinic Network TORONTO, February 15, 2019 – Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has named private healthcare executive Keith White as the Company’s new President […]
Read More
Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow
Research Revenue Totalled $0.6 Million in Q3 2018 Product Data Science Fellow to Lead Evidence-Based Product Research via Proprietary, 10M Point Patient Dataset TORONTO, February 4, 2019 – Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), has appointed Dr. Graham Merry, as the Company’s first Product Data Science Fellow. […]
Read More
Aleafia Health Study Indicates 45% of Patients End Benzodiazepine Use Following Medical Cannabis Treatment
First of its Kind Study Published in Peer-Reviewed Journal, “Cannabis and Cannabinoid Research” Authors Leveraged Aleafia’s 10 Million Point Medical Cannabis Dataset
Read More
Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited
Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator CannaPacific among Australia’s only Federally Licensed Cultivators with projected 108,000 sq. ft. Greenhouse
Read More
Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust
Aleafia Cannabis Complements CannTrust’s Supply for growing Adult-use, Medical Sales
Read More
Aleafia Completes Phase One Construction and Retrofitting of Niagara Greenhouse Facility
Multiple Sales Streams including 15,000 kg Supply Agreement and 50,000 Patient Base
Read More
Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader
View the Aleafia & Emblem Presentation HERE Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres; Aleafia patients to access Emblem’s differentiated, high margin derivative products including capsules, oils and oral sprays, along with award-winning customer service and eCommerce platform; Regulatory acceleration with Aleafia leveraging Emblem’s […]
Read More
Aleafia Announces Results of Special Shareholders Meeting
Company to Immediately Pursue NASDAQ Application Final Stages
Read More
Letter from Chairman Julian Fantino
Over the last month, Aleafia has made significant strides towards achieving our objective of providing the best possible care for our patients, and in turn, providing real value for our shareholders.
Read More
Aleafia Posts Record Revenue in Q3 2018, 36% Increase Over Previous Quarter
First Quarter of Profitability for Clinic and Cannabis Product Divisions 99% of 98,000 kg Annual Cannabis Production Capacity to Come Online in 2019
Read More
Aleafia Closes Transactions with Serruya Private Equity
Transactions Positions Aleafia as Major Supplier, Retailer of Adult-use Cannabis
Read More
Aleafia to Release Q3 Results on November 26
TORONTO, November 23, 2018 /Globe Newswire/ – Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), a highly differentiated cannabis company with major cannabis cultivation and medical clinic operations, will release its financial results and hold its Third Quarter Results Call on November 26, 2018.
Read More
Aleafia and Serruya Private Equity Reach Agreement for National Retail Dispensary, top Performing Brands and $10M Investment
Transactions Positions Aleafia as Major Supplier, Retailer of Adult-use Cannabis
Read More
Aleafia Health to Launch Global Cannabis Education Platform with D2L
Platform to Provide Cannabis Education Courses
Read More
Aleafia to Release Q3 Results on Nov 26, Hold First Ever Results Call
TORONTO, November 12, 2018 /Globe Newswire/ – Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), a highly differentiated cannabis company with major cannabis cultivation and medical clinic operations, will release its financial results and hold its Third Quarter Results Call on November 26, 2018.
Read More